Skip to main content

Table 3 Prevalence of PCV13 serotypes in Western European countries in older populations

From: Pneumococcal serotype evolution in Western Europe

  Age (year) Post-PCV7 period Three most prevalent serotypes Post-higher valent PCV periods Three most prevalent serotypes
Year Among all IPD, % Year Among all IPD, %
Countries in which only PCV13 used
France [18, 20] ≥65 2009 61 19A, 7 F, 3a 2012 42 19A, 3, 7 Fa
Norway [25] >5 2010 52 7 F, 19A, 1, 3 2012 45 7 F, 19A, 3
Switzerland [29] >64 2010–11 66 3, 19A, 7 F 2012 62 3, 19A, 7 F
UK [31] ≥65 2008–10 54 19A, 3, 22 F 2013–14 21 8, 22 F, 3
Countries in which only PCV10 used
Austria [33, 37] >50 2009 69 3, 6A, 14 2013 59 3, 14, 19A
Finland [39] >65 2010 72 14, 3, 23 F 2014 60 3, 22 F, 19A
Netherlands [41] All ages 2010 60 7 F, 8, 19A, 1 2013 45 8, 7 F, 19A
Countries in which both PCV13 and PCV10 used
Germanya [42, 44] >16 2008–2009 56 3, 7 F, 22 Fb 2012–2013 25 23B, 3, 7 Fc
  1. aPneumococcal meningitis; b2007–2010; c2010–2013